227 related articles for article (PubMed ID: 25313101)
1. Current Burden of Hepatitis C Virus Infection Among Injecting Drug Users: A Mini Systematic Review of Prevalence Studies.
Rafiq SM; Banik GR; Khan S; Rashid H; Khandaker G
Infect Disord Drug Targets; 2014; 14(2):93-100. PubMed ID: 25313101
[TBL] [Abstract][Full Text] [Related]
2. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
[TBL] [Abstract][Full Text] [Related]
3. Risk of Hepatitis C virus re-infection following spontaneous viral clearance in injecting drug users: a systematic review.
Corson S; Greenhalgh D; Palmateer N; Weir A; Hutchinson S
Int J Drug Policy; 2011 Mar; 22(2):102-8. PubMed ID: 21112759
[TBL] [Abstract][Full Text] [Related]
4. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
5. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
6. Global estimates of prevalence of HCV infection among injecting drug users.
Aceijas C; Rhodes T
Int J Drug Policy; 2007 Oct; 18(5):352-8. PubMed ID: 17854722
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Xia X; Luo J; Bai J; Yu R
Public Health; 2008 Oct; 122(10):990-1003. PubMed ID: 18486955
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hepatitis C virus infection among injecting drug users in Australia.
Crofts N; Jolley D; Kaldor J; van Beek I; Wodak A
J Epidemiol Community Health; 1997 Dec; 51(6):692-7. PubMed ID: 9519134
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatitis C virus infection among injecting drug users in Sydney.
van Beek I; Buckley R; Stewart M; MacDonald M; Kaldor J
Genitourin Med; 1994 Oct; 70(5):321-4. PubMed ID: 8001943
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
Goldberg D; Cameron S; McMenamin J
Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
[TBL] [Abstract][Full Text] [Related]
12. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
13. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature.
Roy K; Hay G; Andragetti R; Taylor A; Goldberg D; Wiessing L
Epidemiol Infect; 2002 Dec; 129(3):577-85. PubMed ID: 12558341
[TBL] [Abstract][Full Text] [Related]
14. High hepatitis C incidence in new injecting drug users: a policy failure?
Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
[TBL] [Abstract][Full Text] [Related]
15. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
16. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
Aitken CK; Lewis J; Tracy SL; Spelman T; Bowden DS; Bharadwaj M; Drummer H; Hellard M
Hepatology; 2008 Dec; 48(6):1746-52. PubMed ID: 18844233
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.
Ramia S; Melhem NM; Kreidieh K
Infection; 2012 Feb; 40(1):1-10. PubMed ID: 22237470
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil.
Oliveira ML; Bastos FI; Telles PR; Yoshida CF; Schatzmayr HG; Paetzold U; Pauli G; Schreier E
Braz J Med Biol Res; 1999 Sep; 32(9):1107-14. PubMed ID: 10464387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
